Impacting Cancer with HPC: Challenges and Opportunities

Wednesday, 20 November 2019, 12:15pm - 1:15pm

The rate of advancement in the application of AI is creating tremendous opportunities for the use of HPC in advancing research and clinical applications for cancer. Simultaneously, the importance of data and information necessary for successful AI applications to advance research efforts has also grown dramatically. The BoF will focus on opportunities in cancer research and clinical applications for HPC, emphasizing the data challenges and opportunities with AI in key applications like drug discovery and disease diagnosis. A forward focus will be pursued in data availability, model validation, sharing and adoption of developed models, and opportunities for broader collaborative efforts.

Session Leaders:

Patricia Kovatch, Icahn School of Medicine at Mount Sinai

Eric Stahlberg, Frederick National Laboratory of Cancer Research

Thomas Steinke, Zuse Institute Berlin